Major Depressive Disorder Clinical Trials in Memphis, Tennessee

4 studies are recruiting for major depressive disorder in Memphis, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

    The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a l…

    Stage
    Phase 2
    Ages
    18 to 64
    Site
    Clinical Neuroscience Solutions, Inc., Memphis, Tennessee
    Locations
    34 in total
    Run by
    Syndeio Biosciences, Inc

    See if you can join NCT06547489 on ClinicalTrials.gov

  2. A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

    X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    Clinical Neuroscience Solutions, Inc., Memphis, Tennessee
    Locations
    51 in total
    Run by
    Xenon Pharmaceuticals Inc.

    See if you can join NCT06775379 on ClinicalTrials.gov

  3. A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

    Major depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and serious illness that can cause both emotional and physical symptoms such as feelings of sadness, irritability, not being able to focus on activities, ti…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Clinical Neuroscience Solutions /ID# 278192, Memphis, Tennessee
    Locations
    33 in total
    Run by
    AbbVie

    See if you can join NCT07276997 on ClinicalTrials.gov

  4. A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

    This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with major depressive disorder (MDD) who have responded to treatment with AXS-05.

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Clinical Research Site, Memphis, Tennessee
    Locations
    40 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT06223880 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.